Search research articles
Contact Us
Filters
Showing results (11-20 of 272) with videos related to
Page
of 28
Sort By:
Skeletal Radiology
|
October 11, 2014
Primary pseudomyogenic haemangioendothelioma of bone: report of two cases
Alberto Righi, Marco Gambarotti, Piero Picci, et al.
Skeletal Radiology
|
September 21, 2012
Vascular bone tumors: a proposal of a classification based on clinicopathological, radiographic and genetic features
Costantino Errani, Daniel Vanel, Marco Gambarotti, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 22, 2006
The role of surgical margins in treatment of Ewing's sarcoma family tumors: experience of a single institution with 512 patients treated with adjuvant and neoadjuvant chemotherapy
Gaetano Bacci, Alessandra Longhi, Antonio Briccoli, et al.
Pathology, Research and Practice
|
June 8, 2014
Immunoreactivity using anti-ERG monoclonal antibodies in sarcomas is influenced by clone selection
Isidro Machado, Empar Mayordomo-Aranda, Katia Scotlandi, et al.
Cancer
|
January 20, 2006
Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution
Gaetano Bacci, Alessandra Longhi, Michela Versari, et al.
Journal of Cancer Research and Clinical Oncology
|
July 30, 2016
Telangiectatic osteosarcoma: a review of 87 cases
Andrea Angelini, Andreas F Mavrogenis, Giulia Trovarelli, et al.
Virchows Archiv : an International Journal of Pathology
|
February 16, 2018
Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT)
Isidro Machado, Jose Antonio López-Guerrero, Katia Scotlandi, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
October 21, 2016
Pharmacogenomics of genes involved in antifolate drug response and toxicity in osteosarcoma
Claudia Maria Hattinger, Elisa Tavanti, Marilù Fanelli, et al.
Pharmacogenomics
|
November 25, 2016
Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients
Claudia M Hattinger, Serena Vella, Elisa Tavanti, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
December 1, 2016
miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma
Laura Pazzaglia, Chiara Novello, Amalia Conti, et al.
Page
of 28
Search research articles
Search
Showing results (11-20 of 272) with videos related to
Sort By:
Page
of 28
Skeletal Radiology
|
October 11, 2014
Primary pseudomyogenic haemangioendothelioma of bone: report of two cases
Alberto Righi, Marco Gambarotti, Piero Picci, et al.
Skeletal Radiology
|
September 21, 2012
Vascular bone tumors: a proposal of a classification based on clinicopathological, radiographic and genetic features
Costantino Errani, Daniel Vanel, Marco Gambarotti, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 22, 2006
The role of surgical margins in treatment of Ewing's sarcoma family tumors: experience of a single institution with 512 patients treated with adjuvant and neoadjuvant chemotherapy
Gaetano Bacci, Alessandra Longhi, Antonio Briccoli, et al.
Pathology, Research and Practice
|
June 8, 2014
Immunoreactivity using anti-ERG monoclonal antibodies in sarcomas is influenced by clone selection
Isidro Machado, Empar Mayordomo-Aranda, Katia Scotlandi, et al.
Cancer
|
January 20, 2006
Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution
Gaetano Bacci, Alessandra Longhi, Michela Versari, et al.
Journal of Cancer Research and Clinical Oncology
|
July 30, 2016
Telangiectatic osteosarcoma: a review of 87 cases
Andrea Angelini, Andreas F Mavrogenis, Giulia Trovarelli, et al.
Virchows Archiv : an International Journal of Pathology
|
February 16, 2018
Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT)
Isidro Machado, Jose Antonio López-Guerrero, Katia Scotlandi, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
October 21, 2016
Pharmacogenomics of genes involved in antifolate drug response and toxicity in osteosarcoma
Claudia Maria Hattinger, Elisa Tavanti, Marilù Fanelli, et al.
Pharmacogenomics
|
November 25, 2016
Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients
Claudia M Hattinger, Serena Vella, Elisa Tavanti, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
December 1, 2016
miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma
Laura Pazzaglia, Chiara Novello, Amalia Conti, et al.
Page
of 28